Cargando…
CpG island methylation is a common finding in colorectal cancer cell lines
Tumour cell lines are commonly used in colorectal cancer (CRC) research, including studies designed to assess methylation defects. Although many of the known genetic aberrations in CRC cell lines have been comprehensively described, no studies have been performed on their methylation status. In this...
Autores principales: | Suter, C M, Norrie, M, Ku, S L, Cheong, K F, Tomlinson, I, Ward, R L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747532/ https://www.ncbi.nlm.nih.gov/pubmed/12569385 http://dx.doi.org/10.1038/sj.bjc.6600699 |
Ejemplares similares
-
Inactivation of O(6)-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers
por: Bae, S I, et al.
Publicado: (2002) -
CpG island methylation status and mutation analysis of the RB1 gene essential promoter region and protein-binding pocket domain in nervous system tumours
por: Gonzalez-Gomez, P, et al.
Publicado: (2003) -
CpG methylation of MGMT and hMLH1 promoter in hepatocellular carcinoma associated with hepatitis viral infection
por: Matsukura, S, et al.
Publicado: (2003) -
Transcriptional silencing of the Dickkopfs-3 (Dkk-3) gene by CpG hypermethylation in acute lymphoblastic leukaemia
por: Roman-Gomez, J, et al.
Publicado: (2004) -
CpG-island methylation study of liver fluke-related cholangiocarcinoma
por: Sriraksa, R, et al.
Publicado: (2011)